Skip to main content
. 2021 Feb 11;35(2):925–935. doi: 10.1111/jvim.16049

FIGURE 1.

FIGURE 1

Response to treatment with membrane‐based therapeutic plasma exchange (mTPE) in 17 dogs immune‐mediated hematologic disorder (IMHD) (A), including 12 dogs with immune‐mediated hemolytic anemia (IMHA) (B), and 10 dogs with immune‐mediated thrombocytopenia (IMT) (C). The status is shown for the time of discharge (D/C), and at 30 and 90 days, as complete response (CR, dark green), partial response (PR, clear green), no response (NR, clear pink), death (dark brown), and lost to follow‐up (LTFU, white). The overall status represents the last known response status of the dogs, categorized as complete or partial response, no response, and death directly related to the immune disease or its treatment. Dogs that died from other reasons or that were lost to follow‐up are categorized based on their last known response status